ABOUT US
The ENDOSURE TEST is uniquely poised to help facilitate the earliest diagnosis of endometriosis, which in turn can enhance early, appropriate treatment options. Our first-of-its-kind non-invasive, 30-minute diagnostic test for endometriosis offers the promise to improve the lives and livelihoods of the hundreds of millions of women of all ages who suffer from this disease and have waited far too long to be diagnosed. Supporting the Company’s compelling technology is a world-class senior team with transformational skills that will drive the mission of elevating endometriosis care for all women worldwide.
SENIOR EXECUTIVE TEAM
CARLOS BABINI
Chief Executive Officer
Carlos Carlos Babini is an accomplished visionary leader with remarkable achievements in many sectors of the global medical device space. Mr. Babini has a reputation for building world-class organizations and brings more than 40 years of successful commercialization and leadership experience to ENDOSURE, with distinguished performance in public and private companies.
Previously, he has served as CEO of USGI Medical, Inc., a medical company specializing in non-invasive endoluminal procedures, as well as Vice President of AirSeal System Commercialization for Conmed Corporation, and Chief Commercialization Officer at SurgiQuest, Inc., a medical company offering innovative surgical devices for laparoscopic and robotic surgery, prior to its acquisition by Conmed.
Carlos has served as President, International for Curon, Inc. and Chief Sales and Marketing Officer of the medical segment of Vision Sciences Inc., which was acquired by Cogentix Medical and subsequently by Laborie Medical Technologies. He also served as Vice-President of Advanced Technologies and held various executive positions at United States Surgical Corporation, where he was instrumental in launching Minimally Invasive Surgery globally, establishing MIS as a new Surgical Standard of Care along with directing USSC’s initiative that trained thousands of surgeons worldwide prior to its acquisition by Tyco International, LTD. and subsequently by Medtronic.
MARK NOAR
Executive Chairman, Chief of Strategic Development and Medical Officer
Dr.Dr. Mark Noar serves the company as the Chief of Strategic Development, Compliance and Medical Officer. He brings to ENDOSURE more than 40 years of experience in hardware and software development and integration in the medical device industry as well as clinical and research-based practice in gastroenterology and surgery.
Mark is the inventor of the TRICORDER-3L technology and a host of other inventions and innovations in the fields of interventional endoscopy, medical education, and simulation. He is responsible for developing the ENDOSURE TEST and its automated software that supports non-invasive diagnosis of Endometriosis. He has directed multiple clinical research projects, in the fields of obesity, reflux, and gastrointestinal motility, including elevating the importance of Electrogastrography as a successful diagnostic tool.
Dr. Noar has authored numerous publications and produced several award-winning video educational materials and simulators in endoscopy and laparoscopic surgery. He also serves as an advisor to the pharmaceutical, medical device and financial industries. Mark has a history of creating breakthrough technologies and has been credited with saving lives and limiting patient complications worldwide.